TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 42 filers reported holding TFF PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,777 | +2.4% | 16,507 | +37.6% | 0.00% | – |
| Q2 2023 | $5,640 | -74.6% | 12,000 | -62.8% | 0.00% | – |
| Q1 2023 | $22,188 | -41.5% | 32,253 | -10.8% | 0.00% | – |
| Q4 2022 | $37,958 | -87.8% | 36,150 | -52.8% | 0.00% | – |
| Q3 2022 | $311,000 | -60.9% | 76,511 | -45.7% | 0.00% | – |
| Q2 2022 | $796,000 | -56.3% | 140,948 | -51.2% | 0.00% | – |
| Q1 2022 | $1,821,000 | -79.0% | 288,585 | -70.5% | 0.00% | – |
| Q4 2021 | $8,684,000 | +258.5% | 979,152 | +212.1% | 0.00% | – |
| Q3 2021 | $2,422,000 | +9.6% | 313,692 | +36.5% | 0.00% | – |
| Q2 2021 | $2,209,000 | -44.7% | 229,845 | -21.8% | 0.00% | – |
| Q1 2021 | $3,991,000 | -34.3% | 294,103 | -30.6% | 0.00% | – |
| Q4 2020 | $6,070,000 | +105.2% | 423,900 | +164.6% | 0.00% | – |
| Q3 2020 | $2,958,000 | – | 160,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mesirow Financial Investment Management, Inc. | 40,119 | $253,000 | 0.85% |
| GAGNON SECURITIES LLC | 253,019 | $1,597,000 | 0.26% |
| PRINCETON CAPITAL MANAGEMENT LLC | 125,968 | $795,000 | 0.25% |
| DRW Securities, LLC | 1,000,000 | $6,310,000 | 0.17% |
| CARLSON CAPITAL L P | 310,000 | $1,956,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 105,388 | $665,000 | 0.09% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 22,066 | $139,000 | 0.07% |
| Fermata Advisors, LLC | 23,848 | $150,000 | 0.06% |
| SANDERS MORRIS HARRIS LLC | 20,826 | $131,000 | 0.03% |
| Meridian Wealth Advisors, LLC | 11,500 | $73,000 | 0.02% |